These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9353054)

  • 21. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors.
    Bengoechea JA; Najdenski H; Skurnik M
    Mol Microbiol; 2004 Apr; 52(2):451-69. PubMed ID: 15066033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inactivation of the sodA gene of Streptococcus suis type 2 encoding superoxide dismutase leads to reduced virulence to mice.
    Tang Y; Zhang X; Wu W; Lu Z; Fang W
    Vet Microbiol; 2012 Aug; 158(3-4):360-6. PubMed ID: 22424868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The rovA mutant of Yersinia enterocolitica displays differential degrees of virulence depending on the route of infection.
    Dube PH; Handley SA; Revell PA; Miller VL
    Infect Immun; 2003 Jun; 71(6):3512-20. PubMed ID: 12761136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transfer of the core region genes of the Yersinia enterocolitica WA-C serotype O:8 high-pathogenicity island to Y. enterocolitica MRS40, a strain with low levels of pathogenicity, confers a yersiniabactin biosynthesis phenotype and enhanced mouse virulence.
    Pelludat C; Hogardt M; Heesemann J
    Infect Immun; 2002 Apr; 70(4):1832-41. PubMed ID: 11895945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental Yersinia enterocolitica infection in rodents: a model for human yersiniosis.
    Heesemann J; Gaede K; Autenrieth IB
    APMIS; 1993 Jun; 101(6):417-29. PubMed ID: 8363822
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Demonstration and characterization of manganese superoxide dismutase of Providencia alcalifaciens.
    Chen X; Kodama T; Iida T; Honda T
    Microbiol Immunol; 2007; 51(10):951-61. PubMed ID: 17951985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenesis of defined invasion mutants of Yersinia enterocolitica in a BALB/c mouse model of infection.
    Pepe JC; Wachtel MR; Wagar E; Miller VL
    Infect Immun; 1995 Dec; 63(12):4837-48. PubMed ID: 7591144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construction and characterisation of a Yersinia enterocolitica O:8 ompR mutant.
    Dorrell N; Li SR; Everest PH; Dougan G; Wren BW
    FEMS Microbiol Lett; 1998 Aug; 165(1):145-51. PubMed ID: 9711851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role and regulation of the superoxide dismutases of Staphylococcus aureus.
    Karavolos MH; Horsburgh MJ; Ingham E; Foster SJ
    Microbiology (Reading); 2003 Oct; 149(Pt 10):2749-2758. PubMed ID: 14523108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo characterization of an ail mutant of Yersinia enterocolitica.
    Wachtel MR; Miller VL
    Infect Immun; 1995 Jul; 63(7):2541-8. PubMed ID: 7790067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substitution of two histidine residues in YadA protein of Yersinia enterocolitica abrogates collagen binding, cell adherence and mouse virulence.
    Roggenkamp A; Neuberger HR; Flügel A; Schmoll T; Heesemann J
    Mol Microbiol; 1995 Jun; 16(6):1207-19. PubMed ID: 8577254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral and cellular defense against intestinal murine infection with Yersinia enterocolitica.
    Hanski C; Naumann M; Grützkau A; Pluschke G; Friedrich B; Hahn H; Riecken EO
    Infect Immun; 1991 Mar; 59(3):1106-11. PubMed ID: 1997413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Yersinia enterocolitica infection in resistant and susceptible strains of mice.
    Hancock GE; Schaedler RW; MacDonald TT
    Infect Immun; 1986 Jul; 53(1):26-31. PubMed ID: 3721579
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-recombinant V antigen serum promotes uptake of Yersinia enterocolitica serotype 08 by macrophages.
    Roggenkamp A; Leitritz L; Sing A; Kempf VA; Baus K; Heesemann J
    Med Microbiol Immunol; 1999 Dec; 188(3):151-9. PubMed ID: 10776846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of plasmid-encoded antigens of Yersinia enterocolitica in humoral immunity against secondary Y. enterocolitica infection in mice.
    Vogel U; Autenrieth IB; Berner R; Heesemann J
    Microb Pathog; 1993 Jul; 15(1):23-36. PubMed ID: 8412625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Experimental infection of mice with Yersinia enterocolitica serotype O9 by oral and parenteral routes: spreading and enterotropism of virulent yersiniae.
    Ruiz-Bravo A; Moreno E; Sampedro A; Jimenez-Valera M
    Curr Microbiol; 1999 May; 38(5):257-63. PubMed ID: 10355112
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yersinia enterocolitica invasin: a primary role in the initiation of infection.
    Pepe JC; Miller VL
    Proc Natl Acad Sci U S A; 1993 Jul; 90(14):6473-7. PubMed ID: 8341658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective role for heat shock protein-reactive alpha beta T cells in murine yersiniosis.
    Noll A; Roggenkamp A; Heesemann J; Autenrieth IB
    Infect Immun; 1994 Jul; 62(7):2784-91. PubMed ID: 7911784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Invasion and dissemination of Yersinia enterocolitica in the mouse infection model.
    Trülzsch K; Oellerich MF; Heesemann J
    Adv Exp Med Biol; 2007; 603():279-85. PubMed ID: 17966424
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model.
    Schmiel DH; Wagar E; Karamanou L; Weeks D; Miller VL
    Infect Immun; 1998 Aug; 66(8):3941-51. PubMed ID: 9673284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.